Linked Data API

Show Search Form

Search Results

732999
registered interest false remove filter
date less than 2017-06-27more like thismore than 2017-06-27
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading NHS: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment he has made of the effect on obtaining authorisations for new drugs of the UK withdrawing from the European Medicines Agency. more like this
tabling member constituency Linlithgow and East Falkirk more like this
tabling member printed
Martyn Day remove filter
uin 1340 remove filter
answer
answer
is ministerial correction false more like this
date of answer less than 2017-07-05more like thismore than 2017-07-05
answer text <p>The extent to which European Medicines Agency procedures will apply in the United Kingdom after we have exited the European Union will be subject to negotiations. Whatever the outcome of negotiations, the Government will ensure that we have a regulatory system that protects the best interests of patients – without regulatory delay in the approval of new medicines - and encourages innovation.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2017-07-05T08:23:01.003Zmore like thismore than 2017-07-05T08:23:01.003Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4488
label Biography information for Martyn Day more like this